Rate My Professor Premdass Ramdas

Dr. Premdass Ramdas is a Senior Lecturer at Monash University Malaysia's Jeffrey Cheah School of Medicine and Health Sciences, having joined the institution in October 2023. He brings over 13 years of extensive experience in medical biotechnology and health sciences, with a strong emphasis on both teaching and research. His robust academic background includes a PhD in Cancer Proteomics and Genomics from Universiti Malaya, focusing on the investigation of antiproliferative effects of gamma- and delta-tocotrienols in human breast cancer cell lines through genomics and quantitative proteomics. He also holds a Master of Science in Medical Sciences, specializing in Cancer Genomics and Natural Products from International Medical University, and a Bachelor of Science with first-class honors.

Ramdas's research specializations include quantitative proteomics, natural bioactive compounds, epigenetics and nutrigenomics, bioinformatics and data mining, mammalian cell culture, systematic and scoping reviews, AI and big data analysis, cell biology of membrane trafficking, exosomes from human cancer cells, and molecular docking for structure-based drug discovery. His research keywords highlight cancer cell biology, breast cancer, natural compounds, proteomics, mass spectrometry, genomics and transcriptomics, mouse models, bioactive compounds, and 3D cell culture models. He has authored or co-authored 21 peer-reviewed publications, among which notable ones are: "Delta- and Gamma-Tocotrienols Inhibit the Proliferation of HCC2998 Human Colorectal Carcinoma Cells via Modulation of Histone Modification Pathways Involved in DNA Damage Response" (Cell Biology International, 2025), "Inhibition of Proliferation and Induction of Apoptosis by Gamma- or Delta-Tocotrienols in Human Colorectal Carcinoma Cells" (BioMed Research International, 2025), "Insights into the Anticancer Mechanisms Modulated by Gamma and Delta Tocotrienols in Colorectal Cancers" (Nutrition Reviews, 2025), "Protocol for predicting γ-tocotrienol and δ-tocotrienol binding to colorectal cancer-related proteins using Schrödinger’s Maestro and Glide" (STAR Protocols, 2025), and "Delineating the Immunotherapeutic Potential of Vitamin E and Its Analogues in Cancer: A Comprehensive Narrative Review" (BioMed Research International, 2024). His scholarships include the Malaysian Palm Oil Board award for his MSc and the MyBrain15 scholarship for his PhD. Currently, he serves as chief examiner for units such as BRM5012 Techniques in medical biotechnology: Genomics, proteomics and bioinformatics, BRM5021 Biotechnology research project, BRM5015 Biotechnology research studies, and MSM5001 Technology transfer and commercialisation.